Jubilant Ingrevia (BOM:543271) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543271 Jubilant Ingrevia Ltd BOM:543271
83 GF Score
Price ₹624.95
GF Value ₹764.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jubilant Ingrevia Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jubilant Ingrevia's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹ Mil. Jubilant Ingrevia's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹ Mil. Jubilant Ingrevia's annualized EBITDA for the quarter that ended in Jun. 2026 was ₹8,373 Mil. Jubilant Ingrevia's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Jubilant Ingrevia's Debt-to-EBITDA or its related term are showing as below:

BOM:543271' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.28   Med: 1.35   Max: 5.22
Current: 1.22

During the past 6 years, the highest Debt-to-EBITDA Ratio of Jubilant Ingrevia was 5.22. The lowest was 0.28. And the median was 1.35.

BOM:543271's Debt-to-EBITDA is ranked better than
63.31% of 1270 companies
in the Chemicals industry
Industry Median: 1.98 vs BOM:543271: 1.22

Jubilant Ingrevia  (BOM:543271) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Jubilant Ingrevia Debt-to-EBITDA Related Terms


Jubilant Ingrevia Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Jubilant Ingrevia's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jubilant Ingrevia Debt-to-EBITDA Chart

Jubilant Ingrevia Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-EBITDA
Get a 7-Day Free Trial - - - - -

Jubilant Ingrevia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BOM:543271 vs LIN, SHW, ECL: Debt-to-EBITDA Comparison

For the Specialty Chemicals subindustry, Jubilant Ingrevia's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Ingrevia Debt-to-EBITDA vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Jubilant Ingrevia's Debt-to-EBITDA falls into.


BOM:543271
83GF Score
Jubilant Ingrevia Ltd BOM:543271
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jubilant Ingrevia Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jubilant Ingrevia's Debt-to-EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4620.73 + 3297.37) / 5945.31
=1.33

Jubilant Ingrevia's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?

Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued. The current stock price of ₹624.95 is trading 18.2% below its estimated GF Value™ of ₹764.22. GuruFocus considers Jubilant Ingrevia to be Modestly Undervalued.

Key valuation signals for BOM:543271:

  • Debt-to-EBITDA:
  • GF Value™: ₹764.22 vs. price of ₹624.95 (18.2% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jubilant Ingrevia Business Description

Other Exchanges JUBLINGREA:India
Address 1-A, Sector 16-A, Noida, UP, IND, 201301
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
83GF Score

Get the complete analysis for BOM:543271

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹624.95
Price
₹764.22
GF Value